| |
original article |
Journal |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
Trends in Immunotherapy |
2026―May―21 |
Analysis of Molecular Mimicry between Antigens of the SARS-CoV-2 and Dengue Viruses: Implications for Cross-Reactivity |
Carolina Prieto Silva, Marlon Munera, Andres Sanchez |
| 2 |
[GO] |
Trends in Immunotherapy |
2025―Sep―09 |
Prevention and Treatment of COVID-19 and Influenza with Bromhexine and High Doses of Colchicine |
Vanyo Mitev |
| 3 |
[GO] |
Trends in Immunotherapy |
2025―Jul―23 |
The Long Duration Consequence of Using Anti-inflammatory and Immunosuppressive Drugs in the COVID-19 Epidemic |
Ismailov Imetkul |
| 4 |
[GO] |
Trends in Immunotherapy |
2025―Jul―21 |
The Efficacy and Immunogenicity of COVID-19 Vaccine: Special Focus on Patients with Cancer |
Israilova Zeinep Abdukalykovna |
| 5 |
[GO] |
Trends in Immunotherapy |
2025―Mar―28 |
Ultra-Diluted Gelsemium Sempervirens a Known Dna Topoiso- merase i (Top i) Inhibitor Exerts Protective Action Against Sars-Cov- 2 Rbd Induced Cytokine Dysregulation |
Krishnendu Paira, Debasmita Chatterjee, Sayak Ghosh, Pritam Goswami, Satadal Das |
